Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 13
Submit an article Journal homepage
325
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Blastic plasmacytoid dendritic cell neoplasm with history of myeloma and concomitant acute undifferentiated leukemia: Illustration of morphologic and immunophenotypic challenges of an emerging phenomenon

Siba El Husseina Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAORCID Iconhttps://orcid.org/0000-0002-1338-7107
ORCID Icon,
Wei Wanga Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
Sa A. Wanga Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
Sanam Loghavia Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
Xiaoqiong Wanga Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
Lianqun Qiua Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAORCID Iconhttps://orcid.org/0000-0002-4218-4587
ORCID Icon,
Hong Fanga Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
L. Jeffrey Medeirosa Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
Phyu P. Aungb Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
Carlos Torres Cabalab Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA;c Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
Jeffrey L. Jorgensena Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
Naveen Pemmarajud Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
&
Joseph D. Khourya Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USACorrespondence[email protected]
 show all
Pages 3296-3299 | Received 16 Jun 2021, Accepted 14 Jul 2021, Published online: 24 Jul 2021

References

  • Petrella T, Meijer CJ, Dalac S, et al. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Am J Clin Pathol. 2004;122(2):307–313.
  • Sanz-De Pedro M, Wang W, Kanagal-Shamanna R, et al. Myelodysplastic syndromes: laboratory workup in the context of new concepts and classification criteria. Curr Hematol Malig Rep. 2018;13(6):467–476.
  • Guolo FM, Kunkl A, Tedone E, et al. A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated aml patients with worse prognosis while has not predictive value in NPM1-Wt AML. Blood. 2018;132(Supplement 1):5243–5243.
  • Minetto P, Guolo F, Clavio M, et al. A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis. Am J Hematol. 2018;93(2):E33–E5.
  • Hamadeh F, Awadallah A, Meyerson HJ, et al. Flow cytometry identifies a spectrum of maturation in myeloid neoplasms having plasmacytoid dendritic cell differentiation. Cytometry B Clin Cytom. 2020;98(1):43–51.
  • Huang Y, Wang Y, Chang Y, et al. Myeloid neoplasms with elevated plasmacytoid dendritic cell differentiation reflect the maturation process of dendritic cells. Cytometry A. 2020;97(1):61–69.
  • Xiao W, Chan A, Waarts MR, et al. Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia. Blood. 2021;137(10):1377–1391.
  • Zalmai L, Viailly PJ, Biichle S, et al. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape. haematol. 2020.
  • Pemmaraju NK, Khoury JD, Loghavi S, et al. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Commonly Presents in the Setting of Prior or Concomitant Hematologic Malignancies (PCHM): Patient Characteristics and Outcomes in the Rapidly Evolving Modern Targeted Therapy Era. Blood. 2019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.